206 related articles for article (PubMed ID: 31430407)
1. Neuroprotection and immunomodulation of progesterone in the gut of a mouse model of Parkinson's disease.
Jarras H; Bourque M; Poirier AA; Morissette M; Coulombe K; Di Paolo T; Soulet D
J Neuroendocrinol; 2020 Jan; 32(1):e12782. PubMed ID: 31430407
[TBL] [Abstract][Full Text] [Related]
2. GPER1-mediated immunomodulation and neuroprotection in the myenteric plexus of a mouse model of Parkinson's disease.
Côté M; Bourque M; Poirier AA; Aubé B; Morissette M; Di Paolo T; Soulet D
Neurobiol Dis; 2015 Oct; 82():99-113. PubMed ID: 26051538
[TBL] [Abstract][Full Text] [Related]
3. Effects of progesterone administered after MPTP on dopaminergic neurons of male mice.
Litim N; Morissette M; Di Paolo T
Neuropharmacology; 2017 May; 117():209-218. PubMed ID: 28192111
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effect of fasudil on inflammation through PI3K/Akt and Wnt/β-catenin dependent pathways in a mice model of Parkinson's disease.
Zhao Y; Zhang Q; Xi J; Xiao B; Li Y; Ma C
Int J Clin Exp Pathol; 2015; 8(3):2354-64. PubMed ID: 26045742
[TBL] [Abstract][Full Text] [Related]
5. Small molecule TrkB agonist deoxygedunin protects nigrostriatal dopaminergic neurons from 6-OHDA and MPTP induced neurotoxicity in rodents.
Nie S; Xu Y; Chen G; Ma K; Han C; Guo Z; Zhang Z; Ye K; Cao X
Neuropharmacology; 2015 Dec; 99():448-58. PubMed ID: 26282118
[TBL] [Abstract][Full Text] [Related]
6. Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice.
Sathiya S; Ranju V; Kalaivani P; Priya RJ; Sumathy H; Sunil AG; Babu CS
Neuropharmacology; 2013 Oct; 73():98-110. PubMed ID: 23747572
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective and anti-inflammatory effects of the adenosine A(2A) receptor antagonist ST1535 in a MPTP mouse model of Parkinson's disease.
Frau L; Borsini F; Wardas J; Khairnar AS; Schintu N; Morelli M
Synapse; 2011 Mar; 65(3):181-8. PubMed ID: 20665698
[TBL] [Abstract][Full Text] [Related]
8. Effect of the 5α-reductase enzyme inhibitor dutasteride in the brain of intact and parkinsonian mice.
Litim N; Morissette M; Caruso D; Melcangi RC; Di Paolo T
J Steroid Biochem Mol Biol; 2017 Nov; 174():242-256. PubMed ID: 28982631
[TBL] [Abstract][Full Text] [Related]
9. The Nurr1 Ligand,1,1-bis(3'-Indolyl)-1-(
Hammond SL; Popichak KA; Li X; Hunt LG; Richman EH; Damale PU; Chong EKP; Backos DS; Safe S; Tjalkens RB
J Pharmacol Exp Ther; 2018 Jun; 365(3):636-651. PubMed ID: 29626009
[TBL] [Abstract][Full Text] [Related]
10. 7,8-dihydroxyflavone protects 6-OHDA and MPTP induced dopaminergic neurons degeneration through activation of TrkB in rodents.
Luo D; Shi Y; Wang J; Lin Q; Sun Y; Ye K; Yan Q; Zhang H
Neurosci Lett; 2016 May; 620():43-9. PubMed ID: 27019033
[TBL] [Abstract][Full Text] [Related]
11. Phloretin attenuates behavior deficits and neuroinflammatory response in MPTP induced Parkinson's disease in mice.
Zhang G; Yang G; Liu J
Life Sci; 2019 Sep; 232():116600. PubMed ID: 31251998
[TBL] [Abstract][Full Text] [Related]
12. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotection and immunomodulation in the gut of parkinsonian mice with a plasmalogen precursor.
Nadeau J; Smith T; Lamontagne-Proulx J; Bourque M; Al Sweidi S; Jayasinghe D; Ritchie S; Di Paolo T; Soulet D
Brain Res; 2019 Dec; 1725():146460. PubMed ID: 31525350
[TBL] [Abstract][Full Text] [Related]
14. Tinospora cordifolia Suppresses Neuroinflammation in Parkinsonian Mouse Model.
Birla H; Rai SN; Singh SS; Zahra W; Rawat A; Tiwari N; Singh RK; Pathak A; Singh SP
Neuromolecular Med; 2019 Mar; 21(1):42-53. PubMed ID: 30644041
[TBL] [Abstract][Full Text] [Related]
15. Gemfibrozil Protects Dopaminergic Neurons in a Mouse Model of Parkinson's Disease via PPARα-Dependent Astrocytic GDNF Pathway.
Gottschalk CG; Jana M; Roy A; Patel DR; Pahan K
J Neurosci; 2021 Mar; 41(10):2287-2300. PubMed ID: 33514677
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective Effects of Antidepressants via Upregulation of Neurotrophic Factors in the MPTP Model of Parkinson's Disease.
Shadfar S; Kim YG; Katila N; Neupane S; Ojha U; Bhurtel S; Srivastav S; Jeong GS; Park PH; Hong JT; Choi DY
Mol Neurobiol; 2018 Jan; 55(1):554-566. PubMed ID: 27975170
[TBL] [Abstract][Full Text] [Related]
17. Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.
Lee EY; Lee JE; Park JH; Shin IC; Koh HC
Toxicol Lett; 2012 Sep; 213(3):332-44. PubMed ID: 22842585
[TBL] [Abstract][Full Text] [Related]
18. N-Propargyl Caffeamide (PACA) Ameliorates Dopaminergic Neuronal Loss and Motor Dysfunctions in MPTP Mouse Model of Parkinson's Disease and in MPP
Luo D; Zhao J; Cheng Y; Lee SM; Rong J
Mol Neurobiol; 2018 Mar; 55(3):2258-2267. PubMed ID: 28321769
[TBL] [Abstract][Full Text] [Related]
19. Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson's disease.
Wang S; Jing H; Yang H; Liu Z; Guo H; Chai L; Hu L
J Ethnopharmacol; 2015 Apr; 164():247-55. PubMed ID: 25666429
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic effects of paeonol on methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid-induced Parkinson's disease in mice.
Shi X; Chen YH; Liu H; Qu HD
Mol Med Rep; 2016 Sep; 14(3):2397-404. PubMed ID: 27484986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]